Literature DB >> 21702006

Suppression of collagen-induced arthritis in growth arrest and DNA damage-inducible protein 45β-deficient mice.

Yubin Luo1, David L Boyle, Deepa Hammaker, Meghan Edgar, Guido Franzoso, Gary S Firestein.   

Abstract

OBJECTIVE: Growth arrest and DNA damage-inducible protein 45β (GADD45β) is involved in stress responses, cell cycle regulation, and oncogenesis. Previous studies demonstrated that GADD45β deficiency exacerbates K/BxN serum-induced arthritis and experimental allergic encephalomyelitis (EAE) in mice, indicating that GADD45β plays a suppressive role in innate and adaptive immune responses. To further understand how GADD45β regulates autoimmunity, we evaluated collagen-induced arthritis in GADD45β-/- mice.
METHODS: Wild-type (WT) and GADD45β-/- DBA/1 mice were immunized with bovine type II collagen (CII). Serum anticollagen antibody levels were quantified by enzyme-linked immunosorbent assay. Expression of cytokines and matrix metalloproteinases in the joint and spleen was determined by quantitative polymerase chain reaction. The in vitro T cell cytokine response to CII was measured by multiplex analysis. CD4+CD25+ Treg cells and Th17 cells were quantified using flow cytometry.
RESULTS: GADD45β-/- mice showed significantly lower arthritis severity and joint destruction compared with WT mice. MMP-3 and MMP-13 expression was also markedly reduced in GADD45β-/- mice. However, serum anti-CII antibody levels were similar in both groups. FoxP3 and interleukin-10 (IL-10) expression was increased 2-3-fold in splenocytes from arthritic GADD45β-/- mice compared with those from WT mice. Flow cytometric analysis showed greater numbers of CD4+CD25+ Treg cells in the spleen of GADD45β-/- mice than in the spleen of WT mice. In vitro studies showed that interferon-γ and IL-17 production by T cells was significantly decreased in GADD45β-/- mice.
CONCLUSION: Unlike passive K/BxN arthritis and EAE, GADD45β deficiency in CIA was associated with lower arthritis severity, elevated IL-10 expression, decreased IL-17 production, and increased numbers of Treg cells. The data suggest that GADD45β plays a complex role in regulating adaptive immunity and, depending on the model, either enhances or suppresses inflammation.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21702006      PMCID: PMC3183142          DOI: 10.1002/art.30497

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  28 in total

1.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

Authors:  Z Han; D L Boyle; L Chang; B Bennett; M Karin; L Yang; A M Manning; G S Firestein
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Characterization of MyD118, Gadd45, and proliferating cell nuclear antigen (PCNA) interacting domains. PCNA impedes MyD118 AND Gadd45-mediated negative growth control.

Authors:  M Vairapandi; N Azam; A G Balliet; B Hoffman; D A Liebermann
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

3.  Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis.

Authors:  Yuji Yamanishi; David L Boyle; Michael J Pinkoski; Artin Mahboubi; Tesu Lin; Zuoning Han; Nathan J Zvaifler; Douglas R Green; Gary S Firestein
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis.

Authors:  Monica Guma; Jun-ichi Kashiwakura; Brian Crain; Yuko Kawakami; Bruce Beutler; Gary S Firestein; Toshiaki Kawakami; Michael Karin; Maripat Corr
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

5.  IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production.

Authors:  J Yang; H Zhu; T L Murphy; W Ouyang; K M Murphy
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

6.  Regulation of the gadd45beta promoter by NF-kappaB.

Authors:  Rongguan Jin; Enrico De Smaele; Francesca Zazzeroni; Dung U Nguyen; Salvatore Papa; Joy Jones; Carrie Cox; Celine Gelinas; Guido Franzoso
Journal:  DNA Cell Biol       Date:  2002-07       Impact factor: 3.311

Review 7.  MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation--divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation.

Authors:  B-C Sondergaard; N Schultz; S H Madsen; A-C Bay-Jensen; M Kassem; M A Karsdal
Journal:  Osteoarthritis Cartilage       Date:  2009-11-11       Impact factor: 6.576

Review 8.  Evolving concepts of rheumatoid arthritis.

Authors:  Gary S Firestein
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

9.  Kinetic analysis of synovial signalling and gene expression in animal models of arthritis.

Authors:  Akihisa Fukushima; David L Boyle; Maripat Corr; Gary S Firestein
Journal:  Ann Rheum Dis       Date:  2009-05-26       Impact factor: 19.103

10.  Gadd45b and Gadd45g are important for anti-tumor immune responses.

Authors:  Songguang Ju; Yibei Zhu; Lin Liu; Shao Dai; Changyou Li; Elizabeth Chen; Yukai He; Xueguang Zhang; Binfeng Lu
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

View more
  8 in total

Review 1.  Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors.

Authors:  Nunzio Bottini; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

2.  A store-operated calcium channel inhibitor attenuates collagen-induced arthritis.

Authors:  X H Gao; R Gao; Y Z Tian; P McGonigle; J E Barrett; Y Dai; H Hu
Journal:  Br J Pharmacol       Date:  2015-03-27       Impact factor: 8.739

3.  Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-terminal kinase pathway.

Authors:  Sang-il Lee; David L Boyle; Andres Berdeja; Gary S Firestein
Journal:  Arthritis Res Ther       Date:  2012-02-21       Impact factor: 5.156

4.  Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3.

Authors:  Laura Tornatore; Daria Capece; Daniel D'Andrea; Federica Begalli; Daniela Verzella; Jason Bennett; Gary Acton; Elizabeth A Campbell; James Kelly; Michael Tarbit; Nigel Adams; Selina Bannoo; Antonio Leonardi; Annamaria Sandomenico; Domenico Raimondo; Menotti Ruvo; Angela Chambery; Metod Oblak; Magda J Al-Obaidi; Richard S Kaczmarski; Ian Gabriel; Heather E Oakervee; Martin F Kaiser; Ashutosh Wechalekar; Reuben Benjamin; Jane F Apperley; Holger W Auner; Guido Franzoso
Journal:  Toxicol Rep       Date:  2019-04-19

5.  GADD45a and GADD45b Genes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients.

Authors:  Ruei-Nian Li; Yuan-Zhao Lin; Ya-Chun Pan; Chia-Hui Lin; Chia-Chun Tseng; Wan-Yu Sung; Cheng-Chin Wu; Tsan-Teng Ou; Wen-Chan Tsai; Jeng-Hsien Yen
Journal:  J Clin Med       Date:  2019-06-05       Impact factor: 4.241

6.  Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8+ and CD4+ Regulatory T Cells in Lupus.

Authors:  Ram P Singh; Bevra H Hahn; David S Bischoff
Journal:  Front Immunol       Date:  2021-11-19       Impact factor: 7.561

Review 7.  Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment.

Authors:  Ya Luo; Jiqiao Yang; Jing Yu; Xiaowei Liu; Chune Yu; Jianping Hu; Hubing Shi; Xuelei Ma
Journal:  Front Oncol       Date:  2020-01-31       Impact factor: 6.244

8.  Euphorbia Factor L2 ameliorates the Progression of K/BxN Serum-Induced Arthritis by Blocking TLR7 Mediated IRAK4/IKKβ/IRF5 and NF-kB Signaling Pathways.

Authors:  Jing Tang; Xiaolan Cheng; Shiyu Yi; Yuanyuan Zhang; Zhigang Tang; Yutong Zhong; Qiuping Zhang; Bin Pan; Yubin Luo
Journal:  Front Pharmacol       Date:  2021-12-03       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.